Core Insights - The eighth China International Import Expo has commenced, showcasing the integrated diagnostic and treatment solutions by the company, including advanced surgical systems and robots [1][3] - The Ion bronchoscope robot has gained significant attention, highlighting the company's commitment to lung cancer diagnosis and treatment, alongside the launch of a public welfare project aimed at high-risk occupational groups [1][3] Group 1: Event Highlights - The company presented its latest clinical applications and launched the "Lung Guardian" public welfare project in collaboration with multiple partners, focusing on providing comprehensive health protection for high-risk groups [2][3] - The establishment of the "Hema Family Medical Shape Perception Bronchoscope Robot International Training and Demonstration Center" marks a new phase in systematic technology dissemination [1][2] Group 2: Public Welfare Project - The "Lung Guardian" project aims to create a complete chain from screening to treatment for high-risk lung disease occupational groups, emphasizing the importance of early diagnosis and intervention [2][3] - Data indicates that the overall five-year survival rate for lung cancer is 19.7%, while early-stage survival rates can reach 77%-92%, underscoring the critical need for early screening [2][3] Group 3: Industry Impact - The project aligns with the "Technology for Good" philosophy promoted by the expo, facilitating collaboration among medical technology companies, public welfare organizations, and healthcare institutions [4][5] - The initiative is expected to enhance the early diagnosis and treatment of lung cancer, addressing the high incidence and mortality rates associated with the disease in China [5]